Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1

Abstract

Individuals with Behçet's disease suffer from episodic inflammation often affecting the orogenital mucosa, skin and eyes. To discover new susceptibility loci for Behçet's disease, we performed a genome-wide association study (GWAS) of 779,465 SNPs with imputed genotypes in 1,209 Turkish individuals with Behçet's disease and 1,278 controls. We identified new associations at CCR1, STAT4 and KLRC4. Additionally, two SNPs in ERAP1, encoding ERAP1 p.Asp575Asn and p.Arg725Gln alterations, recessively conferred disease risk. These findings were replicated in 1,468 independent Turkish and/or 1,352 Japanese samples (combined meta-analysis P < 2 × 10−9). We also found evidence for interaction between HLA-B*51 and ERAP1 (P = 9 × 10−4). The CCR1 and STAT4 variants were associated with gene expression differences. Three risk loci shared with ankylosing spondylitis and psoriasis (the MHC class I region, ERAP1 and IL23R and the MHC class I–ERAP1 interaction), as well as two loci shared with inflammatory bowel disease (IL23R and IL10) implicate shared pathogenic pathways in the spondyloarthritides and Behçet's disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Manhattan plot of imputed SNPs.
Figure 2: Regional association plots.
Figure 3: Epistasis between HLA-B*51 and ERAP1 rs17482078 (ERAP1 p.Arg725Gln) coding variant in Behçet's disease.
Figure 4: Association of CCR1 and STAT4 variants with gene expression levels and function in human cells.

Similar content being viewed by others

Accession codes

Accessions

Gene Expression Omnibus

References

  1. Sakane, T., Takeno, M., Suzuki, N. & Inaba, G. Behçet's disease. N. Engl. J. Med. 341, 1284–1291 (1999).

    Article  CAS  Google Scholar 

  2. Yazici, H., Fresko, I. & Yurdakul, S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat. Clin. Pract. Rheumatol. 3, 148–155 (2007).

    Article  Google Scholar 

  3. Ono, S., Aoki, K., Sugiura, S., Nakayama, E. & Itakura, K. Letter: HL-A5 and Behçet's disease. Lancet 2, 1383–1384 (1973).

    Article  Google Scholar 

  4. de Menthon, M., Lavalley, M.P., Maldini, C., Guillevin, L. & Mahr, A. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 61, 1287–1296 (2009).

    Article  CAS  Google Scholar 

  5. Gül, A. & Ohno, S. HLA-B*51 and Behçet disease. Ocul. Immunol. Inflamm. 20, 37–43 (2012).

    Article  Google Scholar 

  6. Remmers, E.F. et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat. Genet. 42, 698–702 (2010).

    Article  CAS  Google Scholar 

  7. Mizuki, N. et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat. Genet. 42, 703–706 (2010).

    Article  CAS  Google Scholar 

  8. Moll, J.M., Haslock, I., Macrae, I.F. & Wright, V. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behçet's syndrome. Medicine (Baltimore) 53, 343–364 (1974).

    Article  CAS  Google Scholar 

  9. Chang, H.K. et al. The comparison between Behçet's disease and spondyloarthritides: does Behçet's disease belong to the spondyloarthropathy complex? J. Korean Med. Sci. 17, 524–529 (2002).

    Article  Google Scholar 

  10. Yazici, H., Tuzlaci, M. & Yurdakul, S. A controlled survey of sacroiliitis in Behçet's disease. Ann. Rheum. Dis. 40, 558–559 (1981).

    Article  CAS  Google Scholar 

  11. Olivieri, I., Salvarani, C. & Cantini, F. Is Behçet's disease part of the spondyloarthritis complex? J. Rheumatol. 24, 1870–1872 (1997).

    CAS  PubMed  Google Scholar 

  12. Burton, P.R. et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39, 1329–1337 (2007).

    Article  CAS  Google Scholar 

  13. Duerr, R.H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461–1463 (2006).

    Article  CAS  Google Scholar 

  14. Nair, R.P. et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nat. Genet. 41, 199–204 (2009).

    Article  CAS  Google Scholar 

  15. Ohno, S. et al. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. J. Rheumatol. 31, 1362–1368 (2004).

    CAS  PubMed  Google Scholar 

  16. Dougados, M. & Baeten, D. Spondyloarthritis. Lancet 377, 2127–2137 (2011).

    Article  Google Scholar 

  17. Franke, A. et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42, 1118–1125 (2010).

    Article  CAS  Google Scholar 

  18. Anderson, C.A. et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 43, 246–252 (2011).

    Article  CAS  Google Scholar 

  19. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 335, 1078–1080 (1990).

  20. Haroon, N. & Inman, R.D. Endoplasmic reticulum aminopeptidases: biology and pathogenic potential. Nat. Rev. Rheumatol. 6, 461–467 (2010).

    Article  CAS  Google Scholar 

  21. Sun, L.D. et al. Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat. Genet. 42, 1005–1009 (2010).

    Article  CAS  Google Scholar 

  22. Strange, A. et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 42, 985–990 (2010).

    Article  CAS  Google Scholar 

  23. Evans, D.M. et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 43, 761–767 (2011).

    Article  CAS  Google Scholar 

  24. Kochan, G. et al. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc. Natl. Acad. Sci. USA 108, 7745–7750 (2011).

    Article  CAS  Google Scholar 

  25. York, I.A., Brehm, M.A., Zendzian, S., Towne, C.F. & Rock, K.L. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I–presented peptides in vivo and plays an important role in immunodominance. Proc. Natl. Acad. Sci. USA 103, 9202–9207 (2006).

    Article  CAS  Google Scholar 

  26. Gebreselassie, D., Spiegel, H. & Vukmanovic, S. Sampling of major histocompatibility complex class I–associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides. Hum. Immunol. 67, 894–906 (2006).

    Article  CAS  Google Scholar 

  27. Hayashi, T. et al. Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance. Cancer Res. 66, 563–570 (2006).

    Article  CAS  Google Scholar 

  28. Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727–729 (1999).

    Article  CAS  Google Scholar 

  29. Raulet, D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3, 781–790 (2003).

    Article  CAS  Google Scholar 

  30. Karasneh, J., Gül, A., Ollier, W.E., Silman, A.J. & Worthington, J. Whole-genome screening for susceptibility genes in multicase families with Behçet's disease. Arthritis Rheum. 52, 1836–1842 (2005).

    Article  CAS  Google Scholar 

  31. Zeller, T. et al. Genetics and beyond—the transcriptome of human monocytes and disease susceptibility. PLoS ONE 5, e10693 (2010).

    Article  Google Scholar 

  32. Remmers, E.F. et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 357, 977–986 (2007).

    Article  CAS  Google Scholar 

  33. Abelson, A.K. et al. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann. Rheum. Dis. 68, 1746–1753 (2009).

    Article  CAS  Google Scholar 

  34. Zollner, S. & Pritchard, J.K. Overcoming the winner's curse: estimating penetrance parameters from case-control data. Am. J. Hum. Genet. 80, 605–615 (2007).

    Article  CAS  Google Scholar 

  35. Livneh, A. et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 40, 1879–1885 (1997).

    Article  CAS  Google Scholar 

  36. Stranger, B.E. et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315, 848–853 (2007).

    Article  CAS  Google Scholar 

  37. Niu, N. et al. Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines. Genome Res. 20, 1482–1492 (2010).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This research was supported by the Intramural Research Programs of the National Human Genome Research Institute, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and the Center for Human Immunology, Autoimmunity and Inflammation of the US National Institutes of Health, and by the Istanbul University Research Fund, the Research on Specific Disease of the Health Science Research Grants from the Japanese Ministry of Health, Labor, and Welfare, and the Japan Rheumatism Foundation. We thank A. Wilson for helpful comments on this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

The study was designed by Y. Kirino, G.B., A.G., M.J.O., E.F.R. and D.L.K. Analysis was carried out by Y. Kirino, G.B., Y. Kim, A.M., A.G., E.F.R. and D.L.K. Sample procurement and data generation were performed by Y. Kirino, G.B., Y.I., N.M., I.T.-T., E.S., Y.O., F.S.S., B.E., H.I., Z.E., A.C., N.A., D.U., C.S., A.U., M.T., Y. Kim, G.M.W., M.J.O., A.M., A.G., E.F.R. and D.L.K. The manuscript was written by Y. Kirino, G.B., Y. Kim, M.J.O., A.G., E.F.R. and D.L.K. All authors read and approved the final version of the manuscript.

Corresponding authors

Correspondence to Ahmet Gül, Elaine F Remmers or Daniel L Kastner.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figure 1 and Supplementary Tables 1–6 (PDF 179 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kirino, Y., Bertsias, G., Ishigatsubo, Y. et al. Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet 45, 202–207 (2013). https://doi.org/10.1038/ng.2520

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.2520

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing